Pfizer Settles Anti-Kickback Violation Claims for Nearly $60 Million
Pfizer, Inc., on behalf of its wholly owned subsidiary Biohaven Pharmaceuticals, Inc. has paid almost $60 million dollars to settle claims that the pharmaceutical giant engaged in a kickback scheme from 2020 through 2022. Biohaven was charged with knowingly causing false claims to be submitted to Medicare and other health care programs, as well as […]
